Notes - Segment Information, Etc.

KYORIN Pharmaceutical Co., Ltd. - Filing #7739072

Concept 2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
115,373,000,000 JPY
109,566,000,000 JPY
5,807,000,000 JPY
115,373,000,000 JPY
JPY
119,483,000,000 JPY
119,483,000,000 JPY
5,512,000,000 JPY
JPY
113,970,000,000 JPY
Transactions with other segments
38,000,000 JPY
38,000,000 JPY
0 JPY
JPY
-38,000,000 JPY
JPY
50,000,000 JPY
0 JPY
-50,000,000 JPY
50,000,000 JPY
Other items
Depreciation
3,294,000,000 JPY
3,236,000,000 JPY
58,000,000 JPY
3,619,000,000 JPY
324,000,000 JPY
3,730,000,000 JPY
3,358,000,000 JPY
57,000,000 JPY
372,000,000 JPY
3,300,000,000 JPY
Investments in entities accounted for using equity method
581,000,000 JPY
581,000,000 JPY
JPY
581,000,000 JPY
JPY
551,000,000 JPY
551,000,000 JPY
JPY
JPY
551,000,000 JPY
Increase in property, plant and equipment and intangible assets
2,967,000,000 JPY
2,863,000,000 JPY
103,000,000 JPY
3,065,000,000 JPY
98,000,000 JPY
7,230,000,000 JPY
7,096,000,000 JPY
22,000,000 JPY
134,000,000 JPY
7,073,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.